Hu CD56 BUV395 NCAM16.2 25Tst产品图

Hu CD56 BUV395 NCAM16.2 25Tst

收藏
  • ¥1725.0¥88特惠体验价
  • BD
  • 美国
  • 563555
  • 2026年10月23日
  • Flow Cytometry (FCM)
  • Mouse
  • Human
avatar
  • 企业认证

    点击 QQ 联系

  • 促销:近效期抗体
    备注:详情请咨询客服
    距离结束0 天0 时0 分0 秒
    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商:

      BD Pharmingen

    • 靶点:

      CD56 (NCAM-1)

    • 级别:

      RUO

    • 克隆性:

      单克隆

    • 抗原来源:

      Human

    • 抗体英文名:

      CD56 (NCAM-1) Antibody

    • 抗体名:

      CD56 (NCAM-1)

    • 标记物:

      BUV395

    • 宿主:

      Mouse

    • 适应物种:

      Human

    • 免疫原:

      Immunoaffinity-enriched adult human brain NCAM

    • 亚型:

      Mouse BALB/c IgG2b, κ

    • 形态:

      液体

    • 应用范围:

      Flow Cytometry (FCM)

    • 保存条件:

      2-8℃避光保存

    • 规格:

      25 Tests

    产品概述

    Hu CD56 BUV395 NCAM16.2 25Tst 为 BD Pharmingen 品牌流式抗体,货号 563555,靶向 CD56 (NCAM-1),荧光标记 BUV395,克隆 NCAM16.2 (also known as NCAM 16) (RUO),规格 25 Tests。适用于 Flow cytometry (Routinely Tested) 检测,仅供科研使用(RUO)。

    靶点与抗体说明

    The NCAM16.2 monoclonal antibody specifically binds to human CD56. It recognizes an extracellular immunoglobulin-like domain common to 120, 140, and 180 kDa forms of CD56, also known as the neural cell adhesion molecule (NCAM), NKH1 or MSK39. The CD56 antigen is expressed on approximately 10% to 25% of peripheral blood lymphocytes. It is present on essentially all resting and activated CD16+ natural killer (NK) lymphocytes and approximately 5% of CD3+ peripheral blood lymphocytes. CD3+ CD56+ T lymphocytes comprise a unique subset of cytotoxic T lymphocytes that mediates non-major histocompatibility complex (MHC)-restricted cytotoxicity. CD56 antigen density on NK lymphocytes increases upon cellular activation. The CD56 antigen is involved in neuronal homotypic cell adhesion and cell differentiation during embryogenesis. CD16+ CD56+ NK cells demonstrate reciprocal transfer of an activation state with dendritic cells. The antibody was conjugated to BD Horizon™ BUV395 which has been exclusively developed by BD Biosciences as an optimal dye for use on a 355 nm laser equipped instrument. With an Ex Max at 348 nm  and an Em Max at 395 nm, this dye has virtually no spillover into any other detector. BD Horizon™ BUV395 can be excited with a 355 nm laser and detected with a 379/28 filter.

    核心参数

    货号 563555
    品牌 BD Pharmingen
    克隆号 克隆 NCAM16.2 (also known as NCAM 16) (RUO)
    宿主 Mouse
    同种型 Mouse BALB/c IgG2b, κ
    荧光标记 BUV395
    抗原 / 靶点 CD56 (NCAM-1)
    反应种属 Human
    验证应用 Flow cytometry (Routinely Tested)
    推荐用量 5 µl
    免疫原 Immunoaffinity-enriched adult human brain NCAM
    规格 25 Tests
    存储缓冲液 Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

    荧光染料信息

    BUV395 The BD Horizon Brilliant™ Ultraviolet 395 (BUV395) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This base dye is a polymer fluorochrome with an excitation maximum (Ex Max) of 348-nm and an emission maximum (Em Max) at 395-nm. Driven by BD innovation, BUV395 is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 380-nm (e.g., 379/28-nm bandpass filter). BUV395 is the ideal dye when using only one detector on the ultraviolet laser as it spills into no other detectors and no other fluors spill into it. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye. 格式:BUV395最多激发源:348 nm最多发射源:395 nm

    保存与运输

    建议 2-8℃ 避光保存,请勿冷冻,避免反复冻融。 存储缓冲液:Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

    参考文献

    Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med. 1996; 184(5):1845-1856. (Biology). Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001; 166(11):6477-6482. (Biology). Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer–cell subsets. Trends Immunol. 2001; 22(11):633-640. (Biology). Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman GM. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987; 236(4803):799-806. (Biology). Edelman GM. Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol. 1986; 2:81-116. (Biology). Galandrini R, Tassi I, Mattia G, et al. SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood. 2001; 100(13):4581-4589. (Biology). Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002; 195(3):327-333. (Biology). Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol. 1991; 146(12):4421-4426. (Biology). Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986; 136(12):4480-4486. (Biology). Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989; 169(6):2233-2238. (Biology). Nitta T, Yagita H, Sato K, Okumura K. Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer–target cell interaction. J Exp Med. 1989; 170(5):1757-1761. (Biology). Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med. 1986; 164(3):814-825. (Bio

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 血管里的“斑块清洁工”来了!CD25+调节性T细胞变身CAR-Treg,效果惊人

      4)[15-18]。目前对CD4+CD25+Tregs的效应机制还不十分明确。最初的体外研究明确支持CD4+CD25+Tregs是通过与其他细胞直接接触发挥抑制作用这一观点。因此,细胞-细胞互相接触是该亚型发挥作用的先决条件。 图4. IL-10和TGF-β参与CD4+CD25+Treg(iTREG)的免疫调节作用机制 [16] 4. CD4+CD25+Tregs在多种疾病中的作用 IL2RA,即DC25,主要表达于CD4+CD25+Tregs细胞表面。CD

    • 高福院士团队 Lancet 发文:北京 COVID-19 病例分析表明,疫情爆发期间未出现新变种

      .2.1) 和 22B/Omicron (BF.7 和 BA.5.2) 在 2022 年期间主导了北京的流行感染。但 2022 年 11 月中旬之后,22B 在北京成为绝对主导流行毒株。 图片来源:Lancet 自 2022 年 11 月 14 日起,北京市新增确诊病例大幅增加,共检测确诊病例 413 例,其中本地病例 350 例,境外输入病例 63 例。在这些本地病例中,BF.7 占 265 株 (75.71%),成为 11 月 14 日以后的优势菌株,BA.5.2(16.29%)和 BA

    • 恶性肿瘤病人外周血免疫指标的流式细胞仪检测及免疫治疗前后免疫功能变化的研究

      ,其中年龄和性别构成比与病人组差异无显著性(P>0.05)。 1.2  材料与仪器  小鼠抗人单克隆抗体CD4/CD8/CD3、CD19、CD20、CD3/CD16+56、CD3/HLA-DR、CD3/CD25及同型对照、红细胞裂解液(Optilyse C)均为法国Immunotech公司出品。流式细胞仪(Epics XL·MCL)是美国BECKMAN  COULTER公司生产。 1.3  研究方法  使用直接免疫荧光标记全血溶血法,流式细胞仪测定肿瘤病人外周血淋巴细胞表面抗原表达。  

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3327
    上海优宁维生物科技股份有限公司
    2026年10月23日询价
    ¥2000
    爱必信(上海)生物科技有限公司
    2025年07月13日询价
    询价
    广州东锐科技有限公司
    2026年06月04日询价
    询价
    艾美捷科技有限公司
    2025年07月08日询价
    ¥2085
    苏州奕赛生物科技有限公司
    2026年05月01日询价
    Hu CD56 BUV395 NCAM16.2 25Tst
    ¥1725.0¥88特惠体验价